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Abstract
Pluripotent embryonic stem cells (ESC) are a promising cellular system for generating an unlimited source of tissue for the
treatment of chronic diseases and valuable in vitro differentiation models for drug testing. Our aim was to direct
differentiation of mouse ESC into pancreatic acinar cells, which play key roles in pancreatitis and pancreatic cancer. To that
end, ESC were first differentiated as embryoid bodies and sequentially incubated with activin A, inhibitors of Sonic
hedgehog (Shh) and bone morphogenetic protein (BMP) pathways, fibroblast growth factors (FGF) and retinoic acid (RA) in
order to achieve a stepwise increase in the expression of mRNA transcripts encoding for endodermal and pancreatic
progenitor markers. Subsequent plating in MatrigelH and concomitant modulation of FGF, glucocorticoid, and folllistatin
signalling pathways involved in exocrine differentiation resulted in a significant increase of mRNAs encoding secretory
enzymes and in the number of cells co-expressing their protein products. Also, pancreatic endocrine marker expression was
down-regulated and accompanied by a significant reduction in the number of hormone-expressing cells with a limited
presence of hepatic marker expressing-cells. These findings suggest a selective activation of the acinar differentiation
program. The newly differentiated cells were able to release a-amylase and this feature was greatly improved by lentiviral-
mediated expression of Rbpjl and Ptf1a, two transcription factors involved in the maximal production of digestive enzymes.
This study provides a novel method to produce functional pancreatic exocrine cells from ESC.
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Introduction
Pluripotent embryionic stem cells (ESC) derived from the
inner mass of the pre-implanted embryos have the ability to
self-renew indefinitely in vitro and in appropriate conditions can
be enforced to differentiate into a diversity of specialized cell
types. Recently, it has been shown that endodermal cell
derivatives from ESC can be generated through the in vitro
recapitulation of major developmental signalling pathways
occurring in vivo [1]. For instance, a conserved mechanism for
mesoderm-endoderm lineage commitment involves Nodal,
a TGFb family member, and can be mimicked in vitro by
activin A, yielding a high percentage of endodermal-like cells
[2,3,4]. From this cell population, different studies have used
instructive signals playing a role in pancreatic organogenesis and
b-cell differentiation to commit ESC to similar fates in vitro in
order to obtain a source of replaceable b-cells for diabetic
patients [5,6,7]. In addition to the endocrine compartment, the
pancreas is composed by exocrine cells including ductal and
acinar cells. Acinar cells are responsible for the synthesis of
secretory digestive enzymes, and alterations in the acinar
differentiation program have been linked to exocrine pancreatic
diseases, such as chronic pancreatitis and adenocarcinoma [8].
Therefore, providing normal in vitro models of acinar differen-
tiation from ESC could be helpful to understand better these
processes as primary acinar cultures fail to retain a differentiated
phenotype [9,10]. We previously demonstrated the generation of
acinar cells from mESC on the basis of the genetic selection of
elastase 1 (Ela1)-producing cells and the differentiation with
conditioned medium from the culture of fetal pancreatic tissues
[11]. As this medium contains signals that also promote the
differentiation of other pancreatic cell lineages, the isolation of
the acinar-like cells was required. In this sense, one important
aspect missing in many pancreatic differentiation protocols is to
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assess the extent of selectivity in cell lineage induction. In this
regard, other studies have reported the expression of acinar
markers from ESC by manipulating several developmental
pathways already established for endocrine differentiation or
without examining their role on endocrine gene expression
[12,13,14,15]. Therefore, progress in the knowledge of how
acinar cells are formed during embryogenesis is essential for the
improvement of strategies assessing ESC exocrine differentiation.
Pancreatic organogenesis is a highly regulated process con-
trolled by the gut microenvironment that orchestrates the
expression of key transcription factors that, in turn, specify the
different pancreatic cell types [16]. Both endocrine and exocrine
cells derive from a common pool of progenitors present in the
foregut endoderm. The cross-talk between several pathways
including the inhibition of Shh and RA signalling activation
specifies the pancreatic domain at early stages and regulates the
emergence of Pdx1-expressing progenitors that can be expanded
by FGF10 [17,18,19,20]. In addition, Ptf1a is a bHLH protein
essential for pancreatic formation and in its absence pancreatic
progenitors assume an intestinal fate [21,22]. Gradual reduction of
Ptf1a dosage in mice leads to pancreatic hypoplasia and delayed
exocrine cytodifferentiation [23]. In the adult, Ptf1a is only
expressed in acinar cells as a component of PTF1, a heterotrimeric
transcriptional complex including a ubiquitous E-protein and
Recombination signal-binding protein J–like (Rbpjl) [24,25,26].
During early pancreatic development, Ptf1a requires the in-
teraction with the Rbpj isoform for pancreatic growth and
morphogenesis. Then at the onset of acinar cell development,
Rbpj is replaced by pancreas-restricted Rbpjl, which confers
a higher transcriptional activity to PTF1 leading to maximal
expression of secretory digestive enzymes [27,28].
The aim of this study was to explore alternative routes of
exocrine ESC differentiation. To this purpose: a) we sequentially
activated the in vivo pancreatic patterning signals using previously
described molecules for the formation of endodermal and
pancreatic progenitors together with a new combination of
molecules aimed at the generation of exocrine progenitors and,
b) we enforced Ptf1a and Rbpjl expression using lentiviral gene
transduction. Using this strategy, we demonstrated that the
modulation of FGF, follistatin and glucocorticoid signalling
pathways, which are known to influence exocrine differentiation
in vivo [16,29], promoted the generation of acinar progenitors from
endodermal-like cells in an efficient and selective manner. When
this protocol was coupled to high expression of Ptf1a and Rbpjl
(designed Ptf1aHigh and RbpjlHigh), an important rise in the
expression of digestive enzymes was observed and cells became
responsive to secretagogues. We believe that this new protocol is
improved to others in that: i) it favours the generation of exocrine
progenitors over the production of the endocrine lineage, ii) it
leads to a more mature pattern of the regulatory digestive enzyme
expression modules than other reported protocols [11], and iii)
generates functional cells in a shorter time [11,13,14,15].
Therefore, this approach might be instrumental for a gain of
knowledge of the developmental acinar program and the
establishment of in vitro models for the research on pancreatic
exocrine disease.
Materials and Methods
ESC Culture and Differentiation Conditions
Undifferentiated CGR8 ESC were cultured in Glasgow’s
modified Eagle’s medium (GMEM, Gibco) supplemented with
10% foetal bovine serum (FBS), 0.1 mM 2-mercaptoethanol,
1 mM sodium pyruvate,1% non-essential amino acids (Gibco),
2 mM glutamine, 1% penicillin–streptomycin, and 1000 units/ml
LIF as previously reported [30].
To initiate differentiation, mouse ESC (mESC) were aggre-
gated in suspension (3.46104 cells/ml) in ESC medium
supplemented with 3% Knockout Serum Replacement (SR)
without LIF for 1 day. To generate pancreatic progenitors,
100 ng/ml activin A (R&D Systems) was added to this medium
and embryoid bodies (EB) further grown during 5 days, with
fresh activin A replacement every 2 days. Subsequently, cells
were cultured in medium supplemented with 3% SR, 50 ng/ml
FGF10 (Sigma), 60 ng/ml RA (Sigma), 8.2 ng/ml cyclopamine
(Toronto Research chemicals) and 0.8 ng/ml dorsomorphin
(DM) (Biomol Internat.) for 2 additional days. EB were then
plated in gelatin or Matrigel (BD Biosciences) coated tissue
dishes in 1% SR supplemented medium. To enforce exocrine
differentiation, cells were incubated after 12 hours with 6.2 ng/
ml follistatin (Sigma), 50 ng/ml FGF7 (Sigma), 39 ng/ml
dexamethasone (Sigma), for 5 days and subsequently treated
with follistatin and dexamethasone at the same concentration
for an additional week (Fig. 1). For lentiviral gene transduction
in differentiating ESC, EB were infected at a multiplicity of
infection 1:10 with lentivirus expressing GFP (LvGFP) or the
Ptf1a-ER fusion construct (see above). Medium was changed on
the next day and supplemented with 2 mM 4-hydroxytamoxifen
(Tamox) (Sigma) (Fig. 1).
Lentiviral Vector Production and Gene Transduction
pGAE-CAG-eGFP/WPRE harbours the sequence encoding the
enhanced green fluorescent protein driven of the cytomegalovirus/
chicken b-actin fusion (CAG) promoter. pCAG-Rbpjl was generated
using the Gateway clonase technology using the pCMV-Rbpsuh-l
plasmid provided by R. Macdonald (University of Texas,
Southwestern Medical Center, Dallas, TX) and the 2K7 shuttle
vector, containing the PGK promoter and the blaR selectable gene.
Methods for producing lentiviral particles in 293 cells have been
described elsewhere [31]. Briefly, 293T cells were transfected using
lipofectamine or lipofectamine plus (Invitrogen) with mixtures of
DNAs containing the pGRev or pMD2G plasmids encoding the
VSV-G envelope, the pSIV3+ or p8.9 plasmids encoding the
encapsidation proteins, and the pCAG-Rbpjl or pTRIP plasmid
expressing the Ptf1a fused to the mutated estrogen receptor ligand-
binding domain (ERT2) under the control of the cytomegalovirus
promoter [32]. On the next day, cells were refed with DMEM and
cultured for a further 24 hours. The supernatant was collected,
centrifuged, and filtered to remove cell debris.
For infection of undifferentiated ESC with lentivirus expressing
GFP or Rbpjl, cells were plated at a density of 104 cells in 24-well
plates in 1 ml of medium composed of 100 ml of ESC medium and
900 ml of culture supernatant from virus-producer cells with
polybrene (Sigma) (6 mg/ml). After 48 hours, ESC were
trypsinized, plated out at 104 cells per 10-mm tissue culture dish
and maintained in complete or blasticidin supplemented ESC
medium for 6 days. Cell colonies were then individually amplified
and characterized for transgene expression.
Quantitative RT- PCR Analysis
Total RNA was prepared using the GenElute mammalian
total RNA kit (Sigma) and treated with DNase I (Ambion). Real
time RT-PCR was performed in triplicate on an ABI Prism
7900HT Sequence Detector using the TaqMan RT reagents
(Applied Biosystems) for retrotranscription, the quantitative
SYBR Green PCR kit (Applied Biosystems), and the primers
shown in Table S1. The data were processed using SDS 2.1
software and results were normalized to Hprt mRNA levels.
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Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS for
15 min and permeabilized with 0.1% Triton X-100 and 0.1%
saponin for 20 min. After PBS washes, cells were incubated in
0.1% Tween-20-PBS supplemented with 1% gelatin for 1 hour
and further incubated with primary rabbit antibodies against
Ptf1a [31], Rbpjl (kind gift from R. Wagener, University of
Cologne, Germany), Pdx1 [30], HNF1b (Santa Cruz), a-
amylase (Amyl) (Sigma), carboxypeptidase A1 (Cpa1) (Bio-
genesis), glucagon (Gluc) (Dako), rat liver glycogen synthase
(Gys2) (Sigma-GenoSys), mouse antibodies against chymotryp-
sinogen (Chymo) (Biogenesis), guinea-pig antibodies against
insulin (Ins) (Dako) or goat antibodies against a-fetoprotein
(Afp) (Santa Cruz). Primary antibody was detected using anti-
IgG coupled to Alexa 488, Alexa 555 or Alexa 546 (Invitrogen,
Jackson). Nuclear labeling was performed with ToPro-3 iodide
or DAPI (Molecular Probes). Immunofluorescence staining and
GFP expression were visualized with a Leica TCS-SP2 confocal
microscope. For quantification of positive cells, clusters were
randomly selected from triplicates of two to three independent
experiments and the average value 6 SEM was determined.
Amylase Secretion Assay
Cells were washed with PBS and incubated with fresh cell
culture medium without FBS and supplemented or non-supple-
mented (controls) with 1 pM cholecystokinin octapeptide (CCK)
(Sigma) or with 5 mM carbachol for 30 min at 37uC. Culture
supernatants were then collected and cells lysed in Krebs-Ringer
buffer containing 0.2% BSA. Amylase activity was determined
using the InfinityTM Amylase Liquid Stable Reagent (Termo
Electron). To normalize the amount of amylase secretion, the total
protein content was measured by the Bradford method. Amylase
released into the supernatant and amylase content of the cell
pellets were determined in triplicates.
Statistics
Statistical differences were analyzed by the Student’s t test. p
values as *p,0.1; **p,0.05 and ***p,0.005 were considered
statistically significant.
Results
Directed Pancreatic Acinar Differentiation of mESC in
a Stepwise Fashion through the Regulation of FGF,
Follistatin, and Glucocorticoids Signalling Pathways
Up-regulated expression of genes marking endodermal
and pancreatic cell populations during stages 1–2. Our aim
was to analyze the ability of endoderm enriched ESC populations
to respond to specific signals involved in pancreatic development
in vivo, using culture conditions previously established to drive
mESC into definitive endoderm with minor modifications [33,34].
ESC were aggregated in suspension for one day in low SR
concentration (3%) as EB, to mimic cell interactions occurring
in vivo. On the next day, EB were treated with 100 ng/ml activin A
for up to 4 days to potentiate endoderm specification (stage 1,
Fig. 1). We assessed the expression of early germ-layer specific
markers by qRT-PCR. This treatment enhanced the expression of
Gsc and T/Bra after 3 days of culture (Fig. 2A–B). At day 5, T/Bra
was down-regulated while Gsc was further enhanced, suggesting
that the cell cultures progress through a transient mesendoderm
step. Indeed, from day 1 to day 5, the extra-embryonic endoderm
marker Sox7 and the mesoderm marker Myf5 did not show
a marked increase, whereas the neuroectoderm markers Sox1 and
Zic1 were drastically down-regulated in comparison with non-
treated cultures (Fig. 2B–C). By contrast, the definitive endoder-
mal markers Foxa2, Cxcr4, Gata4 and Sox17 were significantly up-
regulated in the treated cultures at day 5 (Fig. 2A), indicating an
activation of the definitive endoderm differentiation program. In
agreement with endoderm and primitive gut formation, evidenced
by the increase in HNF1b and HNF4a (Fig. 2D), the levels of
mRNAs encoding for pancreatic Pdx1 were already strikingly
enhanced (Fig. 2D), suggesting the activation of a posterior foregut
differentiation program.
To further promote pancreatic specification, activin A-treated
EB were next incubated in suspension during 2 days with FGF10,
RA, the hedgehog-signalling inhibitor cyclopamine as previously
described [5] and DM, a small-molecule inhibitor of BMP
signalling (stage 2, Fig. 1) [35]. As expected, qRT-PCR analysis
showed a continued increase in Pdx1 and HNF1b expression
during this stage in parallel with a rise of a panel of pancreatic
progenitor markers, such as Cpa1, Sox9, Nkx6.1, and Ptf1a, which
indicates the production of a pancreatic lineage specific cell
population (Fig. 3A). The addition of DM at this stage strongly
down-regulated hepatic markers (Afp and Ttr) (Fig. 3B), which is
Figure 1. Protocol for pancreatic acinar differentiation. ESC were induced to differentiate during 19 days though 4 sequential stages including
the generation of definitive endoderm and pancreatic progenitors as well as the formation and expansion of acinar progenitors. d (days); ActA
(activin A); Cyc (cyclopamine); DM (dorsomorphin); Fol (follistatin); Dex (dexamethasone). In some experiments, ESC lines stably expressing GFP or
Rbpjl were differentiated throughout the protocol. At the end of stage 2, cells were infected with a lentivirus expressing an ER-fused Ptf1a construct
or GFP as control, and treated daily with Tamox until the end.
doi:10.1371/journal.pone.0054243.g001
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consistent with the requirement of BMPs for the development of
the hepatic cell lineage [36,37]. By contrast, pancreatic markers or
Cdx2 (a marker of the midgut/posterior gut) remained mostly
unchanged by the treatment (Fig. 3A). Immunofluorescent
stainings confirmed the presence of cells expressing Pdx1 and
Hnf1b in these cultures (about 20% and 38%, respectively)
(Fig. 3C), further suggesting the generation of pancreatic pro-
genitor cells.
Directed generation of pancreatic acinar progenitors
(steps 3 and 4). Next, we plated stage 2-EB in gelatin or
Matrigel-coated tissue dishes and incubated them with a combi-
nation of factors activating specifically developmental exocrine
signalling pathways in vivo. Some of those signals regulate the
proportion of exocrine versus endocrine cells. For instance,
follistatin promotes the growth of exocrine tissue at the expense
of endocrine cells and dexamethasone, a glucocorticoid agonist,
favours acinar differentiation in vitro and in vivo [38,39,40].
Pancreatic culture explants assays demonstrated a role of FGF7
on exocrine cell proliferation and differentiation [41]. These
Figure 2. Gene expression of early germ-layer specific markers at stage 1 by qRT-PCR. Cells were induced to differentiate as EB in the
presence of 100 ng/ml activin A as indicated in Fig. 1. After 3 or 5 days (stage 1), cultures were harvested and subjected to qRT-PCR analysis for the
indicated early germ-layer (A–C) and foregut/pancreatic (D) markers. Histograms show the relative expression levels normalized to the loading
control Hprt. Error bars indicate the standard deviations of 4 experiments. (d), days; T, treated cells; NT, non-treated cells. In A–C, p is calculated as
compared to D1 and in D, as compared to T3. In D, the expression was analyzed from day 3 onwards as some of the markers were undetectable at
day 1.
doi:10.1371/journal.pone.0054243.g002
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Figure 3. Expression of pancreatic progenitor markers at stage 2. A) Cells were induced to differentiate through progression of stages 1 and
2 with or without DM as indicated in Fig. 1. After 5 (stage 1) or 7 (stage 2) days, cultures were harvested and subjected to qRT-PCR analysis for the
indicated markers. Histograms show the relative expression levels normalized to the loading control Hprt. Error bars indicate the standard deviations
Pancreatic Acinar Differentiation of Mouse ESC
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factors were, therefore, sequentially supplemented during stages 3–
4 as described in the Methods section and shown in Fig. 1.
The cells cultured through stages 1–2, and subsequently treated
with pro-exocrine soluble factors until day 19 (T19, whole
protocol) or not treated (NT19) (Fig. 4A), were analyzed for the
expression of an extended panel of pancreatic markers by qRT-
PCR. A prominent induction of mRNA transcripts encoding for
digestive enzymes was observed (Cpa1, Amyl and ChymoB1) in T19
cultures as compared to NT19 (Fig. 4A). It should be noted that
this induction was even more dramatic if T19 cultures are
compared with cells maintained only in 1% SR during the same
period of time (SR19) (Fig. S1A). This indicates that transiting
through stages 1–2 confers to the cells a higher competence to
express spontaneously exocrine markers. In accordance, we
observed increased extracellular release of amylase in T19 in
comparison with SR19 cultures (Fig. S1B).
The up-regulation of digestive enzyme expression correlated
with a discrete to moderate rise of mRNA transcripts encoding for
Ptf1a and Gata4, expressed in acinar progenitors, and Pdx1, which
cooperates with PTF1 to enhance acinar gene expression and
necessary for exocrine development (Fig. 4A) [42,43,44]. Rbpjl
expression was also increased, but the difference was not
statistically significant. Rbpj mRNA levels were reduced as were
those for Mist1. These last two genes are expressed in acinar cells
but are not pancreas-specific markers [45].
On the other hand, the expression of endocrine markers,
including islet hormones insulin 2 (Ins2) and glucagon (Gluc) and
transcription factors marking the endocrine progenitors (Nkx6.1
and Ngn3), was decreased (Fig. 4B). In addition, hepatic Afp and Ttr
were slightly up-regulated in comparison to strong up-regulation
for digestive enzymes (Fig. 4C and Fig. S1A) whereas the gut
marker Cdx2 was not modulated (Fig. 4C).
Expression of selected markers was confirmed by immunoflu-
orescence (Fig. 5). In T19 cultures, large Amyl+ and Chymo+ cell
clusters were found (Fig. 5b–c) as compared to control NT19
cultures (Fig. 5a) (26.566.03% in T19 vs 4.961.05% in NT19,
p,0.05). Also, a large proportion of Chymo+ cells co-expressed
Cpa1 (Fig. 5e) in comparison with controls (Fig. 5d). In line with
qRT-PCR studies, only a subset of these Chymo+ cells were also
Rbpjl+ and were often organized in luminal-like structures (Fig. 5f).
Although Pdx1 mRNA levels were increased in T19 cultures
(Fig. 4A), nuclear Pdx1High was observed in cell subgroups
expressing low Chymo or being negative for this marker (Fig. 5g),
while it was mostly undetectable in cells expressing high levels of
the enzyme. This is in agreement with in vivo patterns in which
only a subpopulation of differentiated acinar cells expresses
Pdx1Low.
By contrast, very few Gluc+ and no Ins+ cells were found in the
T19 condition (Fig. 5l) whereas they were present in large cell
clusters in NT19 cultures (Fig. 5k). Counting assays confirmed
a significant reduction in the number of hormone-expressing cells
using the whole protocol (15.262.5% in NT19 vs 5.261.6% in
T19, p,0.05). The presence of very few double positive Amyl+/
Afp+ cells was observed in NT19 (Fig. 5h) but not in T19 cultures.
Indeed, the few Afp+ were essentially excluded from the large
Amyl+ cell clusters and were, occasionally, located close to isolated
or small groups of Amyl+ cells (Fig. 5i). Likewise, no co-expression
of Chymo and Gys2, responsible for glycogen synthesis in liver,
were found in T19 (Fig. 5j), further suggesting that the generated
exocrine cells arise from true pancreatic progenitors. Altogether,
we show the development of a protocol for pancreatic differen-
tiation, which favours the production of acinar progenitors over
the generation of both pancreatic endocrine and hepatic lineages.
In vitro Differentiation of Transgenic RBPL-ES Cells:
Cooperation with Ptf1a for Maximal Production of
Digestive Enzymes
The fact that the exocrine transcription factor Rbpjl and
a specific set of secretory enzymes, including Trypsin 3 (Prss3),
Carboxyl ester lipase (Cel) and Ela1, induced at later stages of
embryonic development [28] were increased at lower levels with
the T19 protocol, suggested an incomplete activation of the
exocrine differentiation program (Fig. 4A).
To assess the ability of Rbpjl in regulating digestive enzyme
gene modules to achieve advanced differentiation, lentiviral gene
transduction was used to generate ESC cell lines with stable
expression of Rbpjl (RBPL-ES). An ESC line expressing GFP was
used as control (GFP-ES) (Fig. 6A). Characterization of transgene
expression in RBPL-ES by RT-PCR, Western blot (not shown),
and immunofluorescence confirmed the correct expression of
ectopic Rbpjl with a nuclear localization (Fig. 6A). ESC clones
expressing the highest Rbpjl mRNA levels as compared to adult
pancreas were selected by qRT-PCR, such as clone #50, and
behaved similarly in differentiation studies (Fig. 6B, and data not
shown). Because the major known role of Rbpjl is as a Ptf1a
transcriptional partner, the effect of superimposed Ptf1a over-
expression during ESC exocrine differentiation in vitro was
analyzed in parallel. We used a lentivirus expressing the Ptf1a
gene fused to the mutated estrogen receptor ligand-binding
domain (LvPtf1a-ER), allowing an inducible nuclear Ptf1a
expression after Tamox addition. LvPtf1a-ER or LvGFP, as
control, were introduced at the exocrine progenitor stage (stage 3,
Fig. 1), to mimic more closely the timing when Ptf1a levels start to
increase during pancreatogenesis. Transgene expression was
observed in approximately 50% of ESC and addition of 2 mM
Tamox was sufficient to relocate Ptf1a into the nuclear compart-
ment (Fig. 6C). After 5 days of differentiation, control GFP-ESC
infected with LvPtf1a-ER and exposed to Tamox expressed higher
levels of Cpa1 mRNAs as compared with the same DMSO-treated
cells (Fig. 6D). Of note, these later cultures (non-treated cells
infected with LvPtf1a-ER) exhibited higher Ptf1a activity as
compared to LvGFP infected cells, consistent with detectable
nuclear amounts of Ptf1a (Fig. 6C). This likely reflects some
leakage in Ptf1a-ER nuclear translocation. Therefore, we studied
the conditions in which transgenic ES cells were infected with
LvGFP+Tamox versus LvPtf1a-ER+Tamox.
Following the whole differentiation protocol and infection with
LvGFP (Fig. 1), RBPL-ES cultures showed a limited but significant
increase in a subset of secretory enzymes (Cpa1, Amyl, ChymoB1) in
comparison with LvGFP-infected GFP-ES cultures (Fig. 7A), while
the levels of endodermal and pancreatic progenitor markers at
previous stages remained similar in both conditions (not shown).
This differential increase in digestive enzymes between both cell
lines was much stronger when cells were infected with LvPt1a-ER
and treated with Tamox, while exhibiting similar levels of ectopic
Ptf1a mRNAs (Fig. 6E). Notably, the combined action of Ptf1a and
of 3 experiments. p values correspond to comparisons between T5 and T7 and between T7 and T7+ DM. NS, not significant. The effect of the pro-
pancreatic agents was analyzed at the beginning and the end of the corresponding stage. B) Expression of non-pancreatic markers by qRT-PCR as
indicated in A. C) Immunofluorescent staining for HNF1b (a) and Pdx1 (b) in 7-day cultures (stages 1 and 2), 12 hours after plating. Nuclei were stained
in blue. The corresponding negative controls are shown in (a’) and (b’). Scale bars, 10 mm.
doi:10.1371/journal.pone.0054243.g003
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Rbpjl induced not only an increase in early secretory enzyme Ptf1a
targets such as Cpa1, Amyl and ChymoB1 [11,28] but also a highly
significant increase in Prss3, Cel and Ela1 levels, expressed later
during embryonic development (Fig. 7A). This indicates a co-
ordinated activation of the acinar differentiation program leading
to a more mature expression pattern of acinar digestive enzymes.
In addition, enhanced levels of Mist1, involved in terminal
differentiation of acinar cells, was observed in cells overexpressing
Ptf1a and Rbpjl when compared to control LvGFP-infected GFP-
ES cells (Fig. S2) [46]. By contrast, endocrine (except for glucagon)
and hepatic markers were not substantially changed in the same
conditions (Fig. S2), in line with a role of Rbpjl being restricted to
the exocrine compartment [28]. Immunofluorescence assays
showed that in LvPtf1a-infected RBPL ES cultures the percentage
of cells expressing digestive enzymes was 33.866.3 in comparison
to 25.763.1 in LvGFP- infected GFP cells (Fig. S3). Of note, the
number of cells displaying a strong staining for these markers was
increased in cultures overexpressing Ptf1a and Rbpjl relative to
control ones: for amylase, 38.465.3% versus 23.764.7% and for
Cpa1, 43.462.6% versus 22.561.3%, p,0.05.
The increase in the acquisition of more differentiated features
was also reflected by the ability of differentiated RBPL-ES cells to
secrete amylase at physiological concentrations of secretagogues
(Fig. 7B). Thus, an increase of amylase activity was present in these
cultures, both in the intracellular and extracellular compartments
suggesting increased de novo synthesis and secretion of digestive
enzymes in response to secretagogues, which are two well
established functions of these molecules. By contrast, cells that
were not subjected to Ptf1a and RBpjl overexpression were
unresponsive to the same stimuli (Fig. 7B). Overall, these results
indicate the acquisition of functional properties through the
activity of the exocrine transcription factors.
Discussion
In the last years a number of reports have demonstrated the
generation of immature pancreatic endocrine cells from ESC, but
much less is known about the generation of acinar cells from
pluripotent stem cells. Previously, we genetically produced acinar-
like cells from mESC but the protocol was time-consuming and
the selection strategy could favor the purification of cells displaying
higher proliferative ability and less differentiated features [11].
Herein, we aimed to generate exocrine progenitors from mESC
following a directed differentiation method. We were interested in
enhancing acinar versus endocrine differentiation in vitro, using in
the first steps pioneer conditions for definitive endoderm and
pancreatic progenitor production [2,14,33,34,47] and sequential-
ly, a new combination of signals involved in exocrine development.
Among the signalling pathways involved in this cell lineage
decision, follistatin stimulates the generation of amylase-expressing
cells while repressing the formation of insulin-producing cells [38].
Another signal that may enhance acinar differentiation involves
glucocorticoids, which promote acinar differentiation in Pdx1-
expressing cells at the expense of b-cell proliferation [40].
Moreover, glucocorticoids up-regulate the maturation state of
exocrine cells by regulating the expression of amylase, a feature of
advanced acinar differentiation and their secretory capability [48].
Therefore, to sustain exocrine differentiation in ESC cultures, cells
were simultaneously treated with both factors as it is unlikely that
with one single differentiating agent a robust exocrine differenti-
ation would have been achieved [30]. In agreement with the
results of Ren et al. [15], dexamethasone was crucial for an
optimal induction of digestive enzyme expression but only when
added in combination with the other factors. In this respect, co-
treatment with follistatin and FGF7 selectively increased the
expression of these markers but to a lesser extent (data not shown).
However, the previous combination of factors (Activin A+sodium
butyrate+dexamethasone) was somewhat quite inefficient resulting
in nearly two-fold increase in the induction of digestive enzymes as
compared with control cultures [15]. By contrast, in our
experiments there was a substantial increase in the efficiency of
induction of digestive enzymes (a factor of 103–104 times as an
average estimation) with respect to cultures only treated with 1%
SR, which by itself is permissive on ESC acinar differentiation
[49]. To further enhance this efficiency, we co-supplemented our
cultures with T3, a thyroid hormone that selectively promotes
acinar cell proliferation and that cooperates with glucocorticoids in
regulating secretory enzyme expression [50,51]. With addition of
T3 we did not observe a significant impact on the magnitude of
acinar gene expression (data not shown).
Additional detailed studies will be needed to determine the role
of individual differentiating factors in our new method presented
here; however, a recent study showed that FGF7 is able to regulate
acinar differentiation in mESC [14]. Nonetheless, this protocol
was also useful for endocrine differentiation, thus missing a more
specific cell lineage approach. In this regard, we previously showed
that FGF7 induced the expression of both endocrine and exocrine
markers in mESC, supporting its role in the expansion rather the
differentiation of pancreatic or lineage progenitors [30,41].
Therefore, the search for more selective combinations of molecules
for the generation of exocrine cells remains necessary. In this
sense, a valuable contribution of our protocol is that it favours
exocrine differentiation over the endocrine phenotype. It is likely
that the differentiation agents used herein impinge on the early
endocrine commitment of pancreatic progenitors as suggested by
a significant decrease of Ngn3 message levels (Fig. 4). Notably,
Nkx6.1 was also down-regulated in line with recent data showing
a mutually antagonist action with Ptf1a in directing endocrine
versus acinar cell fate choices [52]. In keeping with this,
a significant reduction in the number of cells expressing Ins and
Gluc was observed (Fig. 5). Remarkably, the majority of endocrine
cells co-expressed both hormones in the NT19 condition, which is
indicative of an immature differentiation state and compatible
with a default differentiation pathway.
An important aspect that has not been previously studied refers
to the generally accepted notion that prolonged exposure to
glucocorticoids results in the reprogramming of acinar cells into
hepatic-like cells [15,53]. In our study, the drastic increase in
digestive enzymes was not accompanied by a strong rise of hepatic
markers (Fig. S1A) and the generated acinar progenitors did not
express hepatic Afp and Gys2 (Fig. 5), further indicating that the
produced cells maintain their pancreatic identity. Moreover, the
fact that in our murine model Cpa1, Chymo and Amyl expression
was not affected by BMP inhibition (stage 2, Fig. 3A and data not
shown) argues against a hepatic origin in our conditions [37].
Figure 4. Expression of pancreatic differentiation markers by qRT-PCR at stage 4. Cells were induced to differentiate through-out the
whole protocol as indicated in Fig. 1 and analyzed by qRT-PCR for the expression of exocrine (A), endocrine (B) or hepatic (C) markers. Histograms
show the relative expression levels normalized to the loading control Hprt. Error bars indicate the SEM of at least 3 experiments. Marker expression at
day 19 (T19) was compared to non-treated cells after stage 2 induction and cultured during the same period of time (NT19) to specifically study the
effect of the pro-exocrine molecules. p, as compared to NT19.
doi:10.1371/journal.pone.0054243.g004
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Figure 5. Immunofluorescent analysis of differentiated cell cultures. Staining was performed for Chymo (a–g, j), Amyl (a–c, h–i), Cpa1 (d–e),
Rbpjl (f), Pdx1 (g), Afp (h–i), Gys2 (j), Ins (k–l) and Gluc (k–l) in NT19 (a, d, h, k) and T19 cultures (b–c, e–g, i–j, l) as indicated. Nuclei were stained in
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Although the directed protocol was more selective and
improved the level of induction of digestive enzymes compared
to our previous methods, the acinar-like cells were still immature.
A complementary strategy to soluble factor-induced differentiation
for the generation of functional cell types includes the gain of
function of regulatory genes playing a key role during in vivo
embryonic development. Previously, we showed that combined
Ptf1a and Mist1 expression favours the acquisition of an acinar
phenotype [11]. However, the overexpression of Ptf1a (alone
without the other members of PTF1) only resulted in a strong
induction of early digestive enzymes (Cpa1, ChymoB1) but not of
those reported to be activated at later stages (Amyl, Ela1) [11,31].
The present findings support that a Ptf1a-Rbpjl complex is
required for the acquisition of a mature acinar phenotype. Thus,
Ptf1a and Rbpjl alone could moderately regulate the expression of
early digestive enzymes but it was when co-expressed that the level
of induction increased substantially (Fig. 7A). Importantly, other
Rbpjl-dependent secretory enzymes such as Prss3, Cel and Ela1
blue. Negative controls (m–o) were performed with irrelevant antibodies against rabbit (r), mouse (m), goat (g) or guinea pig (gp) as indicated. Scale
bars: a–b, 50 mm; c–o, 10 mm.
doi:10.1371/journal.pone.0054243.g005
Figure 6. Characterization of transgene expression in undifferentiated and differentiated ESC lines. A) Analysis of transgene expression
in RBPL-ES. Undifferentiated RBPL-ES were stained by immunofluorescence with an anti-Rbpjl antibody or an irrelevant one (green) and with Tropo3
(red) to label nuclei. GFP expression in GFP-ES cells was analyzed by confocal microscopy. The engineered ESC lines displayed a normal karyotype and
retained their self-renewal capacity (not shown). Scale bars, 50 mm. B) Rbpjl mRNA levels of clone # 50 were comparable to those of mouse adult
pancreas by qRT-PCR. C) Immunofluorescence analysis of Ptf1a expression and relocalization in differentiating ESC infected with Lv-Ptf1a-ER and
treated with DMSO (2) or with Tamox (+), two days after. Ptf1a expression is shown in green while the nuclei are stained in red. Asterisks (*) show
nuclear Ptf1a staining in cells non-exposed to Tamox. Scale bars, 10 mm. D) qRT-PCR analysis of Cpa1 expression in GFP-ES cells differentiated through
the protocol until the end of stage 3. Cells were infected with a control LvGFP or the Lv-Ptf1a-ER and incubated with or without Tamox. Ptf1a mRNA
expression is also shown as an indicator of LvPtf1a-ER gene transduction. E) qRT-PCR analysis of ectopic Ptf1a mRNA expression at the end of the
protocol in GFP-ES and RBPL-ES cultures infected with LvPtf1a-ER.
doi:10.1371/journal.pone.0054243.g006
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Figure 7. Digestive enzyme gene expression in transgenic GFP-ES and RBPL-ES differentiated throughout the whole protocol. A)
Analysis of digestive enzyme gene expression by qRT-PCR at the end of the protocol at the indicated culture conditions. T19 cultures of ESC and GFP-
ES infected with LvGFP showed no significant differences in gene expression levels (not shown). Histograms show the relative expression levels
normalized to the loading control Hprt. Error bars indicate the standard deviation of 2 experiments performed in triplicates. p, as compared to GFP-ES
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were significantly increased. It should be noted that the level of
induction for each of these genes was strikingly similar to what
occurs in vivo. In this sense, the grade of reduction in Rbpjl2/2
mice appears more pronounced for Prss3.Cel.Ela1 [28]. As
occurs in vivo, endocrine and hepatic markers were not sub-
stantially affected, despite that Rbpjl is expressed in islets [26,28].
Ultimately, a progression in the developmental program was
further demonstrated by the ability of the generated cells to
become responsive to secretagogues, a hallmark of acinar
functionality. This is a property that is not observed in cells
differentiated only with soluble factors (Fig. 7B) and that has not
been yet demonstrated by other studies [13,14,15]. In summary,
we report a new method, which substantially recapitulates
pancreas development regarding the modulation of the balance
between endocrine and exocrine cell differentiation, and can
provide important hints into the key transcriptional pathways that
delineate exocrine lineage development in ESC.
Supporting Information
Figure S1 Efficiency of digestive enzyme expression in
cells differentiated through-out the whole protocol. A)
qRT-PCR analysis of exocrine gene expression in T19 cultures
was made in comparison with cells incubated in same conditions in
the absence of any inducing factor. Cells were therefore only
cultured in 1% SR for 19 days. Error bars indicate the standard
deviation of 4 experiments. B) Amylase activity in the supernatants
of the indicated cell culture conditions. In T19 cultures, cells did
not respond to acinar secretagogues (not shown).
(TIF)
Figure S2 qPCR analysis for exocrine, endocrine and
hepatic markers in transgenic GFP-ES and RBPL-ES
differentiated through-out the whole protocol. Histograms
show the relative expression levels normalized to the loading
control Hprt. Error bars indicate the standard deviation of 2
experiments performed in triplicates. p, as compared to GFP-ES
infected with LvGFP. LvPtf1a indicates in this figure LvPtf1a-ER
treated with Tamox. NS, not significant.
(TIF)
Figure S3 Immunofluorescent analysis of digestive
enzymes in cultures overexpressing Ptf1a and Rbpjl
differentiated through-out the whole protocol. Staining
was performed for Amyl (a) and Cpa1 (b) in red. Nuclei were
stained in blue. Negative control (c) was performed with an
irrelevant antibody. Scale bars: a–c, 10 mm.
(TIF)
Table S1 List of primers used for qPCR.
(TIF)
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